See More Hear More Watch More Hear More Get on iTunes
StrictlyVC StrictlyVC

Atopix Gets 3.7M In Series A Round

Atopix Therapeutics, a 1.5-year-old, Abingdon, England-based biopharmaceutical company that's developing so-called antagonists for allergic disease, has raised an undisclosed amount of funding from new investor SR One. Atopix had raised £3.7 million in Series A funding. http://goo.gl/lLKbQK

UP NEXT

More from